Professor Rafael (Rafi) Beyar
President, International Friends Associations, Rambam Health Care Campus
Chairman of the Steering Committee, the Eyal Ofer Heart Hospital and the Helmsley Health Discovery Tower, Rambam Health Care Campus
Senior Interventional Cardiologist, Heart Institute, Rambam Health Care Campus
Professor of Medicine and Biomedical Engineering, Women’s Division/Dr. Phillip and Sara Gotlieb, Chair, Technion–Israel Institute of Technology

Rafael (Rafi) Beyar, is the former director of Rambam Health Care Campus, a clinical interventional cardiologist, and a Professor of Medicine and Biomedical Engineering at the Technion. Beyar received an MD from Tel Aviv University (1977), DSc in Biomedical Engineering from the Technion (1983), and MPH from the Bloomberg School of Public Health, Johns Hopkins University (2008). He trained at Rambam and Johns Hopkins Cardiology.

Beyar's Research in the cardiovascular area spanned the interface between medicine and engineering. He has authored more than 200 publications and 15 books, and is the recipient of numerous awards. He served as the Director of Interventional Cardiology at Rambam (1996–2006) and as Dean of the Rappaport Faculty of Medicine (1999–2004), establishing the Johns Hopkins Technion-Collaboration Program. During his term, Professors Hershko and Chiechanover were awarded the 2004 Nobel Prize in Chemistry.

As Rambam’s Director, Beyar successfully led the hospital through the 2006 Second Lebanon War, when it was under missile attack. Following the war, he led development of the hospital’s new campus including the 2,000-bed Sammy Ofer Fortified Underground Emergency Hospital, the Ruth Rappaport Children’s Hospital, the Joseph Fishman Oncology Center, and the Eyal Ofer Heart Hospital. Since 2018, the construction of the Helmsley Health Discovery Tower is underway, in collaboration with the University of Haifa and the Technion. Beyar founded the hospital’s technology transfer company, Rambam MedTech Ltd. (2014), and the MindUp Incubator on Digital Health with Medtronic, IBM Pitango and Impact first in 2017.

Beyar served as chair of the Israeli Basket Committee (2010–2014) and has been the chair of the Steering Committee for the Israeli Organ Transplant Center since 2010 and serves as director of BioRap of the Rappaport Institute and Rambam Med-Tech.

Beyar co-founded InStent, which was acquired by Medtronic (1996) and NaviCath (later Corindus), a Technion Incubator Company (2002), the first-in-the-world robotic coronary intervention, which was acquired by Siemens Healthineers (2019). He founded and co-chairs with Professor Chaim Lotan the international meeting, Innovation in Cardiovascular Interventions (ICI) since 1996.